Ben Creelan - Researcher Profile | RDL Research Database

Publications

2 shown

Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer

Matthew D. Hellmann , Tavi Nathanson , Hira Rizvi +29 more

Combination immune checkpoint blockade has demonstrated promising benefit in lung cancer, but predictors of response to combination therapy are unknown. Using whole-exome sequen...

2018 Cancer Cell 1147 citations

First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer

David P. Carbone , Martin Reck , Luis Paz‐Ares +26 more

Nivolumab was not associated with significantly longer progression-free survival than chemotherapy among patients with previously untreated stage IV or recurrent NSCLC with a PD...

2017 New England Journal of Medicine 2526 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 3,673
Institution: Moffitt Cancer Center

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-2728-8070

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.